Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy

Journal of Cellular Biochemistry

Volumn 110, Issue 4, 2010, Pages 975-981

  Ruan, Lin ^a,b   Wang, Guo Liang ^c   Yi, Hong ^a   Chen, Yan ^a,d   Tang, Can E ^a   Zhang, Peng Fei ^a   Li, Mao Yu ^a   Li, Cui ^a   Peng, Fang ^a   Li, Jian Ng ^a   Chen, Zhu Chu ^a   Xiao, Zhi Qiang ^e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c Hospital of Guangzhou Economic and Technological Development District   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e NONE

Author keywords

NPC; Prognosis; Radiotherapy; RKIP

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; CELL CYCLE; CELL SURVIVAL; METABOLISM; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; NASOPHARYNGEAL NEOPLASMS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHORYLATION; PROTEIN KINASES; RADIATION TOLERANCE;

EID: 77954105867     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22611     Document Type: Article

References (25)

1. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, García JJ, Scott L, Fyfe N, Murray GI, Kolch W. 2006. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24:5672-5679.
2. Banfield MJ, Barker JJ, Perry AC, Brady RL. 1998. Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure 6:1245-1254.
3. Bollengier F, Mahler A. 1988. Localization of the novel neuropolypeptide h3 in subsets of tissues from different species. J Neurochem 50:1210-1214.
4. Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC. 2004. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279:17515-17523.
5. Chen Y, Ouyang GL, Yi H, Li MY, Zhang PF, Li C, Li JL, Liu YF, Chen ZC, Xiao ZQ. 2008. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. J Proteome Res 7: 5254-5262.
6. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Peng F, Duan CJ, Xiao ZQ. 2008. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res 7:2415-2426.
7. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. 2003. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878-889. (Pubitemid 36833879)
8. Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. 2006. Metastasis suppressor gene Raf kinase inhibitor protein(RKIP) is a novel prognostic marker in prostate cancer. Prostate 66:248-256.
9. Grandy DK, Hanneman E, Bunzow J, Shih M, Machida CA, Bidlack JM, Civelli O. 1990. Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography. Mol Endocrinol 4:1370-1376.
10. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, García JJ, Kolch W. 2005. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11:7392-7397.
11. Hori N, Chae KS, Murakawa K, Matoba R, Fukushima A, Okubo K, Matsubara K. 1994. A human cDNA sequence homologue of bovine phosphatidylethanolamine- binding protein. Gene 140:293-294.
12. Keller ET, Fu Z, Brennan M. 2004. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 68:1049-1053.
13. Keller ET, Fu Z, Brennan M. 2005. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. J Cell Biochem 94:273-278.
14. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. 2006. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 131:1208-1217.
15. Park S, Yeung ML, Beach S, Shields JM, Yeung KC. 2005. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 24:3535-3540.
16. Pawlik TM, Keyomarsi K. 2004. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59:928-942. (Pubitemid 38834285)
17. Perry AC, Hall L, Bell AE, Jones R. 1994. Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions. Biochem J 301:235-242. (Pubitemid 24214706)
18. Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande Woude GF, Resau JH, Teh BT. 2002. Met protein expression level correlates with survival in patients with latestage nasopharyngeal carcinoma. Cancer Res 62:589-596.
19. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK. 2004. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64:5186-5192.
20. Seddiqi N, Bollengier F, Alliel PM, Périn JP, Bonnet F, Bucquoy S, Jollès P, Schoentgen F. 1994. Amino acid sequence of the Homo sapiens brain 21-23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. J Mol Evol 39:655-660.
21. Taheri-Kadkhoda Z, Björk-Eriksson T, Nill S, Wilkens JJ, Oelfke U, Johansson KA, Huber PE, Münter MW. 2008. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: A comparative treatment planning study of photons and protons. Radiat Oncol 3:4.
22. Woods Ignatoski KM, Grewal NK, Markwart SM, Vellaichamy A, Chinnaiyan AM, Yeung K, Ray ME, Keller ET. 2008. Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. Int J Radiat Oncol Biol Phys 72:153-160.
23. Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. 2005. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62:672-679.
24. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W. 1999. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401:173-177.
25. Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, Sedivy JM, Kolch W. 2000. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20:3079-3085.